Skip to main content
. 2020 Sep 15;10(25):11428–11443. doi: 10.7150/thno.47432

Figure 8.

Figure 8

A model depicting that inhibition of BRD4 represses SPP1 expression by transcriptionally down-regulating NFKB2 in melanoma. BRD4 promotes NFKB2 expression via direct binding to the NFKB2 promoter. Inhibition of BRD4 by BET inhibitor decreases NFKB2 expression, then represses the expression of SPP1, resulting in impeding melanoma proliferation, migration, and invasion.